Skip to the page
Get started free

Data / Federal awards / NAICS 621991 / THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER

THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER: 42 federal contract awards, $38.3 million obligated (FY2024 to FY2027)

Updated October 6, 2026. Source: USAspending.gov.

THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER (UEI S3GMKS8ELA16), Houston, TX, received 42 federal prime contract awards with $38.3 million obligated in fiscal years 2024 to 2027, from 2 agencies under 9 NAICS codes. Its largest buyer is Department of Health and Human Services ($37.2 million) and its largest code is NAICS 621991 Blood and Organ Banks.

The request: Every federal contract awarded under NAICS 621991, with the winner, the agency and the value. $10 of work on sign-up, no card.

Get contracts in this nicheWatch THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER

SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.

UEI
S3GMKS8ELA16
Location
Houston, TX
Business size
Other Than Small Business
Contract awards
42
Obligated
$38.3 million
First action in window
2023-10-19
Latest action
2026-09-10

Where the work is

NAICS codes, with the other winners in each.

NAICSIndustryAwardsObligated
621991Blood and Organ Banks1$26.7 million
541940Veterinary Services2$5.2 million
541714Research and Development in Biotechnology (except Nanobiotechnology)16$4.6 million
541990All Other Professional, Scientific, and Technical Services3$1.1 million
112990All Other Animal Production11$950,540
811210Electronic and Precision Equipment Repair and Maintenance1$2,763
541711Research and Development in Biotechnology1$0
541720Research and Development in the Social Sciences and Humanities2$-142,426
541712Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)5$-227,385

Buying agencies

AgencyAwardsObligated
Department of Health and Human Services39$37.2 million
Department of Veterans Affairs3$1.1 million

Obligations by fiscal year

Fiscal yearObligated
FY2024$11.6 million
FY2025$12.9 million
FY2026$13.7 million

Contract awards

All 42 awards in fiscal years 2024 to 2027.

Award IDAgencyTypeNAICSWhat it buysObligated in windowAward valueStartsEndsPlace of performanceSource
75R60219C00004Department of Health and Human ServicesDefinitive Contract621991NATIONAL CORD BLOOD INVENTORY$26,737,056$67,006,495September 27, 2019September 3, 2036Houston, TXusaspending.gov
75N97021C00001Department of Health and Human ServicesDefinitive Contract541940OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)$3,652,886$8,683,558December 1, 2020August 31, 2026Houston, TXusaspending.gov
75N98026C00052Department of Health and Human ServicesDefinitive Contract541940OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)$1,578,579$1,578,579September 1, 2026August 31, 2027Bastrop, TXusaspending.gov
75N91025F00001Department of Health and Human ServicesDelivery Order541714PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC)$1,324,125$1,324,125September 25, 2025March 24, 2028Houston, TXusaspending.gov
75F40125C00075Department of Health and Human ServicesDefinitive Contract541714BAA-MD ANDERSON-STATISTICAL DESIGNS AND CONSIDERATIONS FOR DOSE OPTIMIZATION FY25C1FP6$1,184,156$1,184,156September 16, 2025September 29, 2028Beltsville, MDusaspending.gov
36C24524P0903Department of Veterans AffairsPurchase Order541990MED PHYSICS PEER REVIEW SERVICES$1,147,040$1,147,040September 30, 2024September 29, 2027Houston, TXusaspending.gov
75F40126C00055Department of Health and Human ServicesDefinitive Contract541714BAA FY26C1FP7 MD ANDERSON ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRI$752,304$752,304September 30, 2026September 29, 2028Houston, TXusaspending.gov
75N91023F00003Department of Health and Human ServicesDelivery Order541714TARGETING THE A2B ADENOSINE RECEPTOR FOR IMMUNOPREVENTION OF PANCREATIC CANCER$678,909$1,272,481September 15, 2023March 14, 2027Houston, TXusaspending.gov
75N91024F00002Department of Health and Human ServicesDelivery Order541714TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION$551,730$551,730September 20, 2024December 19, 2026Houston, TXusaspending.gov
75F40126P00275Department of Health and Human ServicesPurchase Order112990BORDETELLA-FREE BABOONS FOR PERTUSSIS INFECTION AND VACCINATION STUDIES$368,627$368,627August 31, 2026August 31, 2027Houston, TXusaspending.gov
75F40126P00158Department of Health and Human ServicesPurchase Order112990BORDETELLA-FREE BABOON STUDY$206,192$206,192August 5, 2026August 9, 2027Houston, TXusaspending.gov
75N91023F00002Department of Health and Human ServicesDelivery Order541714TARGETING DKK1 WITH A DNA VACCINE TO PREVENT DEVELOPMENT OF MULTIPLE MYELOMA$147,621$1,249,115June 26, 2023October 25, 2026Houston, TXusaspending.gov
75N98024F00001Department of Health and Human ServicesDelivery Order112990PER DIEM AND TESTING COST FOR THE NIAID OWL COLONY IAW THE CONTRACT SOW$145,000$145,000August 1, 2023July 31, 2024Houston, TXusaspending.gov
75N98025F00003Department of Health and Human ServicesDelivery Order112990V105: NON-HUMAN PRIMATE ACQUISITION$123,000$123,000September 19, 2025September 18, 2026Bethesda, MDusaspending.gov
75N98025F00002Department of Health and Human ServicesDelivery Order112990PER DIEM AND TESTING COST FOR THE NIAID AOTUS NHP COLONY$115,000$115,000August 1, 2024July 31, 2025Houston, TXusaspending.gov
75N98025F00001Department of Health and Human ServicesDelivery Order112990SQUIRREL MONKEY, BOLIVIAN, MIXED GENDER, SPF, IAW CONTRACT SOW AND RFQ N73$40,865$40,865August 1, 2024July 31, 2025Houston, TXusaspending.gov
75N98024F00002Department of Health and Human ServicesDelivery Order112990SQUIRREL MONKEYS, MIXED GENDER, SPF IAW WITH CONTRACT SOW AND RFQ- N73-B$33,435$33,435August 1, 2023July 31, 2024Houston, TXusaspending.gov
36C25726P0378Department of Veterans AffairsPurchase Order811210RATIFICATION FOR CALIBRATION SERVICES$2,763$2,763October 4, 2024May 15, 2026Dallas, TXusaspending.gov
75N91023F00001Department of Health and Human ServicesDelivery Order541714FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION$0$1,293,012July 26, 2023December 25, 2026Houston, TXusaspending.gov
75N91023P00541Department of Health and Human ServicesPurchase Order541990US PEDIATRIC PROTON AND PHOTON THERAPY COHORT AWARD$0$247,116June 27, 2023June 26, 2025Houston, TXusaspending.gov
75N91019D00021Department of Health and Human ServicesIDC541714PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS (POP: 1/25/2019 - 1/24/2024)$0$74,995,000January 25, 2019usaspending.gov
75N98021D00018Department of Health and Human ServicesIDC112990NON-HUMAN PRIMATE ACQUISITION, TESTING, TRANSPORTATION AND HOUSING$0$4,640,856July 20, 2021usaspending.gov
75N91022F00001Department of Health and Human ServicesDelivery Order541714PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGETING THE PARP PATHWAY $0$1,121,090June 1, 2022May 31, 2027Houston, TXusaspending.gov
75N91022F00002Department of Health and Human ServicesDelivery Order541714TARGETING STAT3 TO PREVENT NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)$0$1,097,981September 15, 2022June 14, 2026Houston, TXusaspending.gov
HHSN268200900039CDepartment of Health and Human ServicesDefinitive Contract541711BIOMEDICAL (BASIC)$0$4,878,741August 10, 2009September 13, 2017Houston, TXusaspending.gov
75N91024D00004Department of Health and Human ServicesIDC541714PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM$0$149,995,000January 25, 2024usaspending.gov
HHSN26100008Department of Health and Human ServicesDelivery Order541712IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TR$-598$1,581,195August 1, 2015July 31, 2022Houston, TXusaspending.gov
75N91020F00001Department of Health and Human ServicesDelivery Order541714BASE:PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY&INTERMEDIATE BIOMARKERS TASK ORDER: TARGETING STAT3 TO PREVENT HEPAT$-2,676$840,820June 1, 2020May 31, 2025Houston, TXusaspending.gov
75N91021F00002Department of Health and Human ServicesDelivery Order541714TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE$-2,701$930,247September 16, 2021March 15, 2025Houston, TXusaspending.gov
75N91021F00003Department of Health and Human ServicesDelivery Order541714TASK ORDER TITLE: EVALUATION OF REAL-TIME METABOLIC IMAGING BIOMARKERS FOR DETECTION OF PANCREATIC PREMALIGNANT LESIONS$-3,352$1,162,922September 16, 2021March 15, 2025Houston, TXusaspending.gov
75N91019F00131Department of Health and Human ServicesDelivery Order541714REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST CANCER$-6,396$912,585September 15, 2019September 14, 2023Houston, TXusaspending.gov
75N91019F00129Department of Health and Human ServicesDelivery Order541712OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH$-7,043$2,048,502September 10, 2019September 22, 2024Houston, TXusaspending.gov
75N91019F00132Department of Health and Human ServicesDelivery Order541714CANCER PREVENTION BY VACCINATION AGAINST INDUCED ANTIGENS$-7,267$1,219,900September 15, 2019June 14, 2023Houston, TXusaspending.gov
HHSN26100009Department of Health and Human ServicesDelivery Order541712IGF::OT::IGF VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST$-20,792$501,636September 15, 2015May 9, 2024Houston, TXusaspending.gov
75F40123P00335Department of Health and Human ServicesPurchase Order541720CENTER FOR BIOLOGICS EVALUATION AND RESEARCH DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY$-21,017$150,052August 31, 2023February 28, 2025Houston, TXusaspending.gov
75F40121P00534Department of Health and Human ServicesPurchase Order112990MERKELOMV-AP STUDY (BABOONS)$-22,608$202,107September 2, 2021September 2, 2022Silver Spring, MDusaspending.gov
75F40120P00519Department of Health and Human ServicesPurchase Order112990DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY$-28,562$202,650August 17, 2020March 31, 2023Houston, TXusaspending.gov
HHSN26300005Department of Health and Human ServicesDelivery Order112990SQUIRREL MONKEYS, BOLIVIA, EITHER GENDER, GREATER THAN 700 GRAM, ESTABLISHED PAIRS PREFERRED, SPF (REF. N1)$-30,408$0January 16, 2015January 10, 2025Dickerson, MDusaspending.gov
HHSN26100012Department of Health and Human ServicesDelivery Order541712IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER$-33,929$556,189September 1, 2017April 30, 2022Houston, TXusaspending.gov
36C24521C0180Department of Veterans AffairsDefinitive Contract541990MEDICAL PHYSICS PEER REVIEW OF RADIATION THERAPY QUALITY ASSURANCE OPERATIONS$-42,205$972,225September 30, 2021March 12, 2025Richmond, VAusaspending.gov
75F40121C00180Department of Health and Human ServicesDefinitive Contract541720IMMUNOGENICITY STUDY IN BABOONS FOLLOWING VACCINATION WITH EXPERIMENTAL ACELLULAR PERTUSSIS VACCINES.$-121,409$425,645September 28, 2021March 27, 2024Silver Spring, MDusaspending.gov
HHSN26100011Department of Health and Human ServicesDelivery Order541712IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BRE$-165,023$2,186,265September 19, 2016September 18, 2023Houston, TXusaspending.gov

Also on SpecStream

Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.